News
NaviSci Q3/ 2021 Progress updates in the development of our NaviSci™ Intelligent Surgical System for the localization and removal of early-stage lung tumors
NaviSci Q3/ 2021 Progress updates in the development of our NaviSci™ Intelligent Surgical System for the localization and removal of early-stage lung tumors Read more
Navigation Sciences™ Awarded $400,000 NCI SBIR/STTR Program Grant to Support Development of NaviSci™ Intelligent Surgical System Use in Removal of Early-Stage Lung Tumors
Navigation Sciences™ Awarded $400,000 NCI SBIR/STTR Program Grant to Support Development of NaviSci™ Intelligent Surgical System Use in Removal of Early-Stage Lung Tumors Read more
Joining Navigation Sciences board of directors are Carl Berke, Ph.D. Partner at the MassGeneral Brigham Venture, and Steve Gullans, Ph.D. Principal at Gullans Advisory
Joining Navigation Sciences board of directors are Carl Berke, Ph.D. Partner at the MassGeneral Brigham Venture, and Steve Gullans, Ph.D. Principal at Gullans Advisory Read more
Navigation Sciences awarded U.S. patent covering NaviSci™ Intelligent Surgery system and other recent company progress
Navigation Sciences awarded U.S. patent covering NaviSci™ Intelligent Surgery system and other recent company progress Read more
Navigating Through Early-Stage Lung Cancer, published in Medical Device and Diagnostic Industry Online
Navigating Through Early-Stage Lung Cancer, published in Medical Device and Diagnostic Industry Online Read more
Navigation Sciences™ Begins First-in-Human Clinical Feasibility Trial of its Pioneering, NaviSci™ System for Tissue-Conserving Removal of Early-Stage Lung Tumors
Navigation Sciences™ Begins First-in-Human Clinical Feasibility Trial of its Pioneering, NaviSci™ System for Tissue-Conserving Removal of Early-Stage Lung Tumors Read more
